antihama
12 minutes ago
While I don't read their posts, it looks like their argument has changed, So now it's not about SAP buy-in, or data lock, or getting the DCVax-L trial data published in a prestigious journal, or getting regulatory approval, or NWBO existing as an ongoing entity. I see now it's about manufacturing pr